Follow us Facebook Icon

News

08 January, 2023

Department of Biotechnology announces the scientific completion of India's first qHPV vaccine ‘CERVAVAC’

Serum Institute CEO, Adar Poonawalla was conferred with the first Dr. Patangrao Kadam Memorial Award at the inauguration of the Bharti Super Specialty Hospital at Bharti Vidyapeeth, Pune on Sunday 8th January 2023. Read more...

01 September 2022

Department of Biotechnology announces the scientific completion of India's first qHPV vaccine ‘CERVAVAC’

Dr. Jitendra Singh, Hon'ble Minister of State of the Ministry of Science and Technology & Earth Sciences announced India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine 'CERVAVAC' for the prevention of cervical cancer. Read more...

24 August 2022

Serum Institute CEO Adar Poonawalla calls on Hon'ble Prime Minister Shri. Narendra Modi

Serum Institute of India CEO Adar Poonawalla on Tuesday called on Hon'ble Prime Minister Shri. Narendra Modi and congratulated him for his leadership in the fight against the COVID-19 pandemic.... Read more...

Cyrus Poonawalla

Dr. Cyrus S. Poonawalla

Chairman and Managing Director
Mr. Adar C. Poonawalla

Mr. Adar C. Poonawalla

CEO
Natasha Poonawalla

Mrs. Natasha A. Poonawalla

Executive Director - Serum Institute of India
Chairperson - Villoo Poonawalla Foundation

OUR COMPANIES

Poonawalla Group

The Cyrus Poonawalla Group of Companies headquartered in Pune, India are a diversified group with business interests that include Pharmaceuticals & Biotechnology, Finance, Clean Energy, Hospitality & Realty and Aviation.

EXPLORE